Parenteral Fansidar in falciparum malaria. 1988

T Harinasuta, and C Viravan, and P Buranasin
Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Harinasuta, and C Viravan, and P Buranasin
May 1979, Australian family physician,
T Harinasuta, and C Viravan, and P Buranasin
September 1979, Lancet (London, England),
T Harinasuta, and C Viravan, and P Buranasin
March 1971, The Southeast Asian journal of tropical medicine and public health,
T Harinasuta, and C Viravan, and P Buranasin
January 1984, British medical journal (Clinical research ed.),
T Harinasuta, and C Viravan, and P Buranasin
January 1981, Lancet (London, England),
T Harinasuta, and C Viravan, and P Buranasin
December 1980, Lancet (London, England),
T Harinasuta, and C Viravan, and P Buranasin
August 1985, Lancet (London, England),
T Harinasuta, and C Viravan, and P Buranasin
January 1981, Transactions of the Royal Society of Tropical Medicine and Hygiene,
T Harinasuta, and C Viravan, and P Buranasin
August 1983, Revista de saude publica,
T Harinasuta, and C Viravan, and P Buranasin
March 1983, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!